Physician

Jeffrey N Wentzloff, M.D.

According to 2025 Medicare claims, Jeffrey Wentzloff, M.D. (NPI: 1508840273) practices ophthalmology in the Traverse City, MI market, with the plurality of this provider's patient population coming from Grand Traverse, MI. This provider's primary affiliated billing organization is GRAND TRAVERSE OPHTHALMOLOGY CLINIC PC (NPI: 1265426514; TIN: 38-1950606) and primary practice location at 49686-8683. Wentzloff is affiliated with the Northern Michigan Health Network dba NPO-CIN (ACO ID: D0067), participating under the REACH model.

Wentzloff's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 894 traditional Medicare patients, billed 2,872 HCPCS/CPT codes, and received $252,098 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 4,977 prescription claims across 975 beneficiaries totaling $394,838 in drug costs, led by Rocklatan (Netarsudil Mesylat/Latanoprost). 2016 DME data shows 11 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $485,725 to $252,098. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,519	4,974	$485,725
2016	1,457	4,944	$443,773
2017	1,456	5,072	$444,919
2018	1,382	4,644	$439,548
2019	1,365	4,654	$461,466
2020	1,072	3,517	$323,683
2021	1,122	3,633	$339,089
2022	1,020	3,282	$295,587
2023	875	2,753	$237,647
2024	894	2,872	$252,098

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,034	5,033	$396,337
2016	1,010	4,730	$429,641
2017	1,061	4,624	$478,296
2018	916	4,447	$489,508
2019	890	4,386	$459,846
2020	898	4,182	$438,910
2021	950	4,382	$452,225
2022	969	4,576	$434,547
2023	962	4,787	$439,289
2024	975	4,977	$394,838

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	11	11	$562
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92014	Established patient complete exam of visual system	446	467	$70
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	286	367	$58
92083	Exam of visual field with extended testing	342	359	$39
92250	Photography of the retina	233	234	$23
92133	Imaging of optic nerve	274	278	$21

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Rocklatan	Netarsudil Mesylat/Latanoprost	80	4,426	$52,281
Lumigan	Bimatoprost	82	6,124	$50,650
Timolol Maleate	Timolol Maleate	908	62,560	$35,674
Latanoprost	Latanoprost	1,444	109,704	$33,054
Rhopressa	Netarsudil Mesylate	38	2,376	$23,820

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Jeffrey N. Wentzloff, M.D.?

Tedicare shows public-source Medicare data for Jeffrey N. Wentzloff, M.D. (NPI 1508840273), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey N. Wentzloff, M.D. have ACO affiliation data?

Jeffrey N. Wentzloff, M.D. is shown with ACO affiliation data for Northern Michigan Health Network dba NPO-CIN (REACH, ACO ID D0067).

What billing organization is linked to Jeffrey N. Wentzloff, M.D.?

Jeffrey N. Wentzloff, M.D. is linked to GRAND TRAVERSE OPHTHALMOLOGY CLINIC PC (billing NPI 1265426514) in the available physician profile data.

Does Jeffrey N. Wentzloff, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.